fruquintinib Capsules 1 mg, 5 mg
Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Unavailable markets
United States
Manufacturer #36625
A pharmaceutical manufacturer engaged in the research, development, manufacture and commercialization of a variety of pharmaceutical products, including finished dosage forms such as capsules, tablets and injections as well as active pharmaceutical ingredients. The company focuses on multiple therapeutic areas including diabetic, cardiovascular, oncology, anesthetic and analgesic treatments, and operates manufacturing facilities that have passed relevant GMP standards to support quality and compliance in production of its pharmaceutical products.
Manufacturer usually replies in 7 days